Governance Genmab A/S

GMAB

DK0010272202

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 17/07/2025 pm IST			5-day change	1st Jan Change
1,420.50 ^DKK	+1.00%		+1.86%	-4.82%

16/07	Genmab A/S Announces Sales Results of Darzalex for Second Quarter of 2025	CI
16/07	Genmab says net sales of Darzalex in Q2 $3,539 mln	RE

Executive Committee: Genmab A/S

Manager

Positions heldSince

Jan van de Winkel

64 year

Chief Executive Officer	01/06/2010
Founder	11/06/1998
President	01/06/2010

Andrew Carlsen

Investor Relations Contact

Rayne Waller

Chief Tech/Sci/R&D Officer

16/08/2024

Christopher Cozic

47 year

Human Resources Officer

01/01/2017

Tahamtan Ahmadi

52 year

Chief Tech/Sci/R&D Officer

01/02/2021

Anthony Pagano

47 year

Director of Finance/CFO

01/03/2020

Gregory David Emil Mueller

53 year

General Counsel

01/07/2025

Composition of the Board of Directors: Genmab A/S

Director

CommitteesSince

Deirdre Connelly

64 year

Compensation Committee	26/03/2020
Governance Committee Chair	26/03/2020
Nominating Committee Chair	26/03/2020
Audit Committee	26/03/2020
Executive Committee
Governance Committee	10/08/2016
Compensation Committee Chair	26/05/2016
Finance Committee	26/03/2020

Anders Gersel Pedersen

74 year

Audit Committee	01/01/2020
Finance Committee	01/01/2014
Governance Committee	01/11/2003
Nominating Committee	01/11/2003
Compensation Committee Chair	01/01/2020
Compensation Committee	29/05/2018
Nominating Committee Chair	01/01/2020

Elizabeth O'Farrell

60 year

Audit Committee	29/03/2022
Compensation Committee Chair	01/01/2020
Audit Committee Chair	01/02/2021
Finance Committee	29/03/2022
Compensation Committee	29/03/2022

Pernille Erenbjerg

58 year

Governance Committee	01/01/2015
Nominating Committee	01/01/2015
Audit Committee Chair	27/04/2022
Finance Committee Chair	01/01/2015

Rolf K. Hoffmann

65 year

Audit Committee	01/01/2017
Finance Committee	01/01/2017
Compensation Committee	15/06/2023
Nominating Committee	15/06/2023

Paolo Augusto Paoletti

74 year

Compensation Committee

Mijke Zachariasse

52 year

Director/Board Member

29/03/2019

Martin Schultz

50 year

Director/Board Member

01/01/2022

Latest Appointments: Genmab A/S

Genmab Announces Changes to Its Executive Committee	01/07	CI
Genmab's Chief Legal Officer Steps Down; Successor Named	01/07	MT
Aadi Bioscience, Inc. Appoints Baiteng Zhao to its Board of Directors	20/12	CI
HOOKIPA Pharma Names Julie O'Neill Nonexecutive Chair	30/24/30	MT
Genmab Names First Chief Technology, Chief Commercial Officers; COO to Exit	16/24/16	MT
Genmab COO Anthony Mancini Departs; Firm Names New CTO, CCO	16/24/16	MT
Genmab Operations Chief Anthony Mancini Departing	16/24/16	MT

More news

Former Officers and Directors: Genmab A/S

Insider

Positions held

SinceUntil

Birgitte Stephensen

General Counsel

01/07/2025

Anthony Mancini

Chief Operating Officer

23/03/2020

16/08/2024

Takahiro Hamatani

Director/Board Member

01/01/2022

Jonathan Peacock

Director/Board Member	26/03/2020	15/11/2021
Independent Dir/Board Member	26/03/2020	15/11/2021

Suba Krishnan

Corporate Officer/Principal

01/09/2019

01/11/2020

Michael K. Bauer

Chief Tech/Sci/R&D Officer	-	01/10/2020
Corporate Officer/Principal	01/08/2012	-

Mats Gunnar Pettersson

Director/Board Member	17/04/2013	-
Chairman	17/04/2013	26/03/2020
Independent Dir/Board Member	17/04/2013	26/03/2020

David Andrew Eatwell

Director of Finance/CFO

02/06/2008

29/02/2020

Richard Gordon Hibbert

Director/Board Member

01/01/2016

29/03/2019

Rachel Curtis Gravesen

Investor Relations Contact	01/05/2011	11/03/2019
Public Communications Contact	01/05/2011	11/03/2019

Rima Bawarsh Nassar

Director/Board Member

01/01/2019

Burt Malkiel

Director/Board Member	01/04/2010	01/06/2018
Independent Dir/Board Member	01/01/2007	01/06/2018

Paul W. H. I. Parren

Chief Tech/Sci/R&D Officer

01/09/2001

01/08/2017

Steen Lisby

Chief Tech/Sci/R&D Officer

01/01/2008

01/01/2017

Peter Storm Kristensen

Director/Board Member

01/01/2016

Hans Henrik Munch-Jensen

Director/Board Member	26/03/2009	01/01/2015
Independent Dir/Board Member	01/01/2007	01/01/2015

Karsten Havkrog Pedersen

Director/Board Member	01/03/2002	01/04/2013
Independent Dir/Board Member	01/03/2002	01/04/2013

Michael Blair Widmer

Director/Board Member	28/03/2012	01/04/2013
Chairman	01/03/2002	27/04/2012
Independent Dir/Board Member	01/03/2002	01/04/2013

Antonius Theodorus M Wilderbeek

Director/Board Member	06/04/2011	01/04/2013
Independent Dir/Board Member	06/04/2011	01/04/2013

Daniel John Bruno

Comptroller/Controller/Auditor	01/01/2008	01/04/2013
Director/Board Member	25/06/2010	01/04/2013
Comptroller/Controller/Auditor	01/01/2016	-
Director/Board Member	01/01/2016	01/08/2020

Patrick van Berkel

Chief Tech/Sci/R&D Officer

01/01/2003

01/01/2012

Helle Husted

Investor Relations Contact	28/04/2011	01/05/2011
Public Communications Contact	-	28/04/2011

Joris Wilms

Corporate Officer/Principal

01/10/2008

01/12/2010

Eva Ehrnrooth

Chief Tech/Sci/R&D Officer

01/06/2008

01/02/2010

Lisa N. Drakeman

Founder	01/01/1999	01/01/2010
President	01/01/1999	01/01/2010

Ernst H. Schweizer

Director/Board Member

26/03/2009

15/04/2009

Barry Littlejohns

Chief Operating Officer

28/05/2010

Bo Kruse

Comptroller/Controller/Auditor	01/01/2000	01/01/2005
Director of Finance/CFO	01/01/2005	02/06/2008

Claus Juan Møller-San Pedro

Chief Operating Officer

01/01/1999

01/01/2008

Irwin Lerner

Director/Board Member

31/01/2007

Hanne Jensen

Corporate Officer/Principal

01/01/1999

Christina Hahner

Chief Administrative Officer	01/01/2005	-
Public Communications Contact	01/01/2005	-

Annarie Lyles

Corporate Officer/Principal

28/05/2010

Joseph Fred Yospe

Comptroller/Controller/Auditor

01/09/2002

01/09/2004

Nedjad Losic

Director/Board Member	25/06/2010	-
Corporate Officer/Principal	01/01/2004	-

Michael Wolff Jensen

Director of Finance/CFO

01/01/2000

01/01/2003

Jorgen Petersen

Chief Tech/Sci/R&D Officer

01/01/2002

Tom Vink

Director/Board Member	25/06/2010	-
Corporate Officer/Principal	01/01/2002	-

Rikke Glahn Ren

Corporate Officer/Principal

01/01/2001

Ole Baadsgaard

Chief Tech/Sci/R&D Officer	28/05/2010	-
Corporate Officer/Principal	28/05/2010	28/05/2010

Donald Lee Drakeman

Founder

11/06/1998

Florian Schönharting

Founder

11/06/1998

Dorrit T. Andersen

General Counsel

Torben Lund-Hansen

Corporate Officer/Principal

Flemming Heise Pedersen

Director/Board Member

Linda Basse

Chief Tech/Sci/R&D Officer

Jesper Zeuthen

Chairman

Francesco de Rubertis

Director/Board Member

Eva Steiness

Chairman

Age distribution of managers

Parity Men Women

Male	15
Female	4

Of which Executive Committee

Male	7
Female	0

Of which Directors

Male	5
Female	3

Revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

Revenue revisions (1 month)

EPS revisions (1 year)

EPS revisions (4 months)

ESG MSCI

ESG

Environment

Social

Governance

Controversy

Ethical controversies

Human rights controversies

Tax subsidies controversies

Sharia compliant

Genmab A/S specializes in the research and development of human and therapeutic antibodies intended for treating cancers, infectious diseases, rheumatoid arthritis, etc. Net sales break down by type of income as follows: - royalties (80.6%); - income from research and development (9.3%); - other (10.1%): primarily income from partnership agreement. At the end of 2024, the group had a portfolio of more than 20 products in clinical development phase and 20 in preclinical development phase. Net sales are distributed geographically as follows: Denmark (91.9%), the United States (4.2%) and Japan (3.9%).

Employees

2,638

Sector

Biotechnology & Medical Research

Calendar

07/08 - Q2 2025 Earnings Release

More about the company